| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 0 | ||||
| Sells | 9 | -1.03M | 100% | $33.78 | -$34.9M |
| Net | -9 | -1.03M | -100% | -$34.9M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Christopher Anzalone | Chief Executive Officer, Director | $262M | -$27.4M | -9.46% | 19 Dec 2025 |
| Patrick O'Brien | COO and General Counsel | $10.4M | -$736K | -6.62% | 04 Jan 2025 |
| Kenneth Myszkowski | Chief Financial Officer | $8.97M | -$893K | -9.06% | 04 Jan 2025 |
| James Hamilton | Chief Medical Officer | $7.42M | -$2.37M | -24.2% | 01 Oct 2025 |
| Javier San | Chief Medical Officer | $7.42M | 04 Jan 2024 | ||
| MICHAEL PERRY | Director | $4.98M | -$992K | -16.6% | 16 Dec 2025 |
| James Hassard | Chief Commercial Officer | $3.95M | 22 Jun 2021 | ||
| William Waddill | Director | $3.88M | -$566K | -12.7% | 19 Dec 2025 |
| Tracie Oliver | Chief Commercial Officer | $3.21M | 02 Jul 2024 | ||
| Mauro Ferrari | Director | $3.1M | -$493K | -13.7% | 16 Dec 2025 |
| DOUGLAS B. GIVEN | Director | $2.74M | 16 Dec 2024 | ||
| Victoria Vakiener | Director | $2.44M | -$679K | -21.8% | 19 Dec 2025 |
| ADEOYE OLUKOTUN | Director | $2.3M | -$697K | -23.2% | 19 Dec 2025 |
| Hongbo Lu | Director | $2.22M | 16 Dec 2025 | ||
| DOUGLAS S. INGRAM | Director | $1.87M | 16 Dec 2025 | ||
| Daniel Joseph Apel | Chief Financial Officer | $1.7M | 15 Apr 2025 | ||
| Marianne De Backer | Director | $1.17M | 10 Jan 2023 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|